Conference Reports for NATAP

Back

IDSA/IDWeek 2015, October 7-11, San Diego     HCV at IDSA, Treatment Study Results in HIV/HCV Coinfected, Cascade & Barriers to Care (10/23/15)   Antiretroviral Therapy in HIV-infected Adults Receiving Medical Care in the United States: Medical Monitoring Project, 2009-2012 (10/21/15)   HCV Cascade/Barriers in Philadelphia - "Meet the Professor: Overcoming barriers to HCV care" (10/21/15)   DAA Cure Rate 75% in HCV/HIV Cohort With Ongoing Barriers to Care - Mark Mascolini (10/21/15)   Exploring the Benefits of an Enhanced Social Work Intervention within the HCV Cascade of Care (10/19/15)   HCV Cascade/Denver - Impact of Interferon-Era HCV Treatment Restrictions on Current Referral and Treatment Trends (10/19/15)   Gender, Ethnicity, IDU, and Risk for HCV Among New York City Jail Inmates (10/19/15)   Diagnosed, staged and untreated: Hepatitis C fibrosis severity by transient elastography (TE) in an inner city clinic (10/19/15)   Linkage to Care for Hepatitis C: Creating a Cascade of Care to Identify Gaps at the Individual Hospital Level (Bellevue Hospital-NYC) (10/19/15)   Hepatitis C Virus (HCV) In Young Suburban Heroin Users In New Jersey; Part Of The Second Wave Of Hepatitis C (10/19/15)   C-EDGE: INTEGRATED ANALYSIS FROM THE PHASE 2/3 STUDIES OF ELBASVIR / GRAZOPREVIR IN PATIENTS WITH HCV/HIV (2) (10/19/15)   Continued Rising Mortality from Hepatitis C Virus in the United States, 2003-2013 (10/19/15)   A Study of the Knowledge And Beliefs Held by Patients Infected with HIV and Their HIV Health Care Providers Regarding Single Tablet Regimens (STR). (KNABSTR Study) (10/19/15)   Long-Term Safety and Efficacy of Dolutegravir in HIV Treatment-Experienced Adolescents (10/19/15)   A Study of the Knowledge And Beliefs Held by Patients Infected with HIV and Their HIV Health Care Providers Regarding Single Tablet Regimens (STR). (KNABSTR Study) (10/16/15)   2014 Affordable Care Act Enrollment of AIDS Drug Assistance Program Clients and Associated HIV Outcomes.....ACA Enrollment Improves Viral Load suppression by 45% [slides presented are included in this report] (10/16/15)   Affordable Care Act helps Virginia improve HIV outcomes (10/16/15)   US ART Guideline Picks Linked to Better Viral Suppression, Fewer Side Effects - Mark Mascolini - (10/16/15)   US Clinicians Largely Follow Guidelines in Picking First-Line Regimens - Mark Mascolini - (10/16/15)   Sub-500 Current CD4 Count Linked to Unsuccessful Aging in US Clinic - Mark Mascolini - (10/16/15)   Low Pneumococcal Colonization Rate in HIV+ Adults in PCV-13 Vaccine Era - Mark Mascolini - (10/16/15)   Behavioral and Clinical Factors Among HIV-infected Women in Care ≥ Age 50 Years - United States, 2009-2011 ..... 37.5% >50 years of age....60-62% Black - written by Mark Mascolini - (10/16/15)   Perinatally Infected Hispanics Have Higher Resistance Rates Than Blacks in Houston - written by Mark Mascolini - (10/16/15)   Perinatally Infected Hispanics Have Higher Resistance Rates Than Blacks in Houston - written by Mark Mascolini - (10/16/15)   New US HIV Prevention Guidelines Underline Antiretroviral Use - written by Mark Mascolini - (10/16/15)   Under 3% With HIV Complete HPV Vaccine Series in Large Denver Survey - written by Mark Mascolini - (10/16/15)   Rectal and Pharyngeal Screening Yields Higher GC/CT Positive Rates in HIV+ Men - written by Mark Mascolini - (10/16/15)   ART Feasible During Bone Marrow Transplant--Enfuvirtide a Safe Option - written by Mark Mascolini - (10/16/15)   Community-Acquired Pneumonia More Frequent With HIV in Veterans Cohort - written by Mark Mascolini - (10/16/15)   "Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users: analysis of patient electronic medical record data" - written by Mark Mascolini - (10/16/15)   HIV+ Nonnative English Speakers Have Higher Odds of Neurocognitive Impairment - written by Mark Mascolini - (10/16/15)   A Longitudinal Analysis of Fractures (and Osteoporisis) Among Human Immunodeficiency Virus (HIV) Patients in the USA.....incidence & prevalence increased by 50% in Medicare (10/15/15)   A Prospective Comparison of Arterial Stiffness and Inflammation in Adults with HIV/Hepatitis C Co-Infection, HIV Infection and Healthy Controls..... "markers of inflammation and monocyte activation were significantly higher among HIV/HCV participants suggesting a possible mechanism for the increased risk of CVD reported in this patient group." (10/15/15)   A Longitudinal Analysis of Cardiovascular Conditions and Related Comorbidities Among Human Immunodeficiency Virus (HIV) Patients in the USA (10/15/15)   A Longitudinal Analysis of Cardiovascular and Fracture Rates Among HIV-infected Patients in the USA with Commercial and Medicaid Insurance (10/15/15)   Switching From a TDF to a TAF-Based Single Tablet Regimen: Week 48 Data in HIV-1 Infected Virologically Suppressed Adults (10/15/15)   HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 48 Subgroup Analysis (10/15/15)   Lack of Drug Interactions between Boosted and Unboosted Tenofovir Alafenamide-based Antiretroviral Single Tablet Regimens (Emtricitabine/Rilpivirine/Tenofovir Alafenamide and Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) and the anti-HCV Single Tablet Regimen Ledipasvir/Sofosbuvir...... "R/F/TAF or E/C/F/TAF may be coadministered with LDV/SOF without dose modification." (10/15/15)   Influence of Age on Outcomes in HIV-Infected Adults Initiating Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate With Elvitegravir, Cobicistat, and Emtricitabine (10/15/15)   Safety and Efficacy of TAF vs TDF Single-Tablet Regimen in HIV-1 Treatment-Naïve Black and Nonblack Patients Through Week 48 (10/15/15)   Long Term Testosterone Replacement Therapy (TRT) use in HIV Patients and New Cardiovascular Events (CVE) (10/15/15)   Pharmacy-based Resource Requirements to Obtain HCV Therapy for HIV/HCV Co-Infected Patients (10/15/15)   C-EDGE: INTEGRATED ANALYSIS FROM THE PHASE 2/3 STUDIES of ELBASVIR / GRAZOPREVIR in HIV PATIENTS WITH HCV/HIV (10/15/15)   12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens (10/15/15)   12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by Black Race (10/15/15)   Ledipasvir/Sofosbuvir Is Safe and Effective for the Treatment of Patients with Genotype 1 Chronic HCV Infection in Both HCV Mono- and HIV/HCV Coinfected Patients (10/15/15)   Strategic Simplification: The Efficacy and Safety of Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Plus Darunavir (DRV) in Treatment-Experienced HIV-1-Infected Adults (NCT01968551) (10/13/15)   Lack of Drug Interactions Between Boosted and Unboosted TAF-Based Antiretroviral Single-Tablet Regimens (E/C/F/TAF, R/F/TAF) and the anti-HCV Single-Tablet Regimen Ledipasvir/Sofosbuvir (10/13/15)   SVR12 Similar in HCV-1 Patients With or Without HIV in Four LDV/SOF Trials - written by Mark Mascolini - (10/13/15)   Follow-up Screening Rates Low for Breast and Cervical Cancer in HIV+ Women - written by Mark Mascolini - (10/13/15)   Better Renal and Bone (But Not Lipid) Changes After Switch From E/C/F/TDF to E/C/F/TAF - written by Mark Mascolini - (10/13/15)   HIV+ Blacks in VA 30% More Likely to Have Poor Hypertension or Diabetes Control - written by Mark Mascolini - (10/13/15)   Sustained Viral Control With Switch to E/C/F/TAF Plus DRV in Experienced - written by Mark Mascolini - (10/13/15)   Switch From ADAP to Obamacare Linked to HIV Control in Virginia - written by Mark Mascolini - (10/13/15)   Week-48 Subgroup Responses to Attachment Inhibitor in Phase 2b Trial - written by Mark Mascolini - (10/13/15)   HIV, Hypertension, and Diabetes Control Vary Between and Within HIV Clinics - written by Mark Mascolini - (10/13/15)   HIV Testing Rate Only 16% in High-Risk Hospital Pneumonia Patients - written by Mark Mascolini - (10/10/15)   Urine Screening Alone Misses Most Chlamydia and Gonorrhea in HIV+ MSM - written by Mark Mascolini - (10/10/15)